Actively Recruiting
Remote Smoking Cessation in Hospitalized Cardiac Patients
Led by University of Vermont Medical Center · Updated on 2025-01-20
50
Participants Needed
1
Research Sites
172 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects. The proposed trial can provide significant knowledge for promoting adherence to smoking cessation guidelines in patients with cardiac disease
CONDITIONS
Official Title
Remote Smoking Cessation in Hospitalized Cardiac Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized for an acute coronary event including myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)
- Live within 30 miles of the University of Vermont Medical Center
- Aged 18 years or older
- Current cigarette smoker, defined as any cigarette use in the week before hospital admission and averaging more than 5 cigarettes per day over the past 3 months
You will not qualify if you...
- Severe dementia or Alzheimer's disease
- Active cancer, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance
- Exercise-limiting vascular or neuromuscular disease
- Non-English speaking
- No reliable smartphone access
- Current regular use of smokeless tobacco or other non-combusted tobacco products
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Vermont Medical Center
Burlington, Vermont, United States, 05405
Actively Recruiting
Research Team
S
Sherrie Khadanga, MD
CONTACT
D
Diann Gaalema, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here